Coston, McIsaac & Partners FBIOX — FIDELITY SELECT BIOTECHNOLOGY

Ownership history in Coston, McIsaac & Partners  ·  17 quarters on record

AI Ownership Summary

Coston, McIsaac & Partners reported FIDELITY SELECT BIOTECHNOLOGY (FBIOX) in 17 quarterly 13F filings from 2024 Q2 through 2026 Q3. The latest visible filing shows FBIOX at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this FBIOX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Coston, McIsaac & Partners's position in FIDELITY SELECT BIOTECHNOLOGY, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q3

FBIOX was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2025 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q2 to 2026 Q3

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Coston, McIsaac & Partners held FBIOX — position size vs. price
% of Fund (quarterly)    FBIOX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q3 UNCHANGED — — — 76 — 0% 0.00% $2K 2026-11-06 $28.97
2026 Q2 ADDED — — — 76 +3 +4.1% 0.00% $2K 2026-08-12 $29.65
2026 Q1 UNCHANGED — — — 73 — 0% 0.00% $1K 2026-04-22 $25.49
2025 Q4 REDUCED 22.3% +2.1% ❌ 73 -21 -22.3% 0.00% $1K 2026-02-03 $24.88
2025 Q3 UNCHANGED — — — 94 — 0% 0.00% $2K 2025-11-05 $21.91
2025 Q2 UNCHANGED — — — 94 — 0% 0.00% $1K 2025-08-12 $18.59
2025 Q1 UNCHANGED — — — 94 — 0% 0.00% $1K 2025-05-13 $16.03
2024 Q4 ADDED — — — 94 +1 +1.1% 0.00% $1K 2025-01-23 $17.90
2024 Q3 ADDED — — — 93 +5 +5.7% 0.00% $1K 2024-10-22 $20.06
2024 Q2 ADDED — — — 88 +1 +1.1% 0.00% $1K 2024-07-31 $19.46
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding FBIOX

As of 2026 Q3 — sorted by position size

NEVILLE RODIE & SHAW INC 3Y 7Y 0.08% Financial Gravity Asset Management, Inc. 3Y 7Y 0.0%

FAQ About Coston, McIsaac & Partners and FBIOX

These are the practical questions this page is built to answer before you even open the full history table.

How long has Coston, McIsaac & Partners reported owning FBIOX?

Coston, McIsaac & Partners reported FBIOX across 10 quarterly 13F filings, from 2024 Q2 through 2026 Q3.

What was the largest reported FBIOX position in Coston, McIsaac & Partners's portfolio?

The largest reported portfolio weight for FBIOX was 0.00% in 2025 Q3.

What is the latest reported FBIOX position on this page?

The most recent filing on this page is 2026 Q3, when Coston, McIsaac & Partners reported 76 shares, equal to 0.00% of portfolio, with an estimated market value of $2K.

What does the chart on this FBIOX ownership page compare?

The chart compares Coston, McIsaac & Partners's quarterly FBIOX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Coston, McIsaac & Partners time their FBIOX position?

Based on 13F filing dates vs. subsequent FBIOX price moves, Coston, McIsaac & Partners correctly timed 6 out of 11 reported position changes (55%). The annualised alpha on FBIOX relative to SPY over the holding period was -0.5%.

← Back to Coston, McIsaac & Partners Holdings